A Patient with CTLA-4 Haploinsufficiency Presenting Gastric Cancer

Journal of Clinical Immunology

Volumn 36, Issue 1, 2016, Pages 28-32

  Hayakawa, Seiichi ^a   Okada, Satoshi ^a   Tsumura, Miyuki ^a   Sakata, Sonoko ^a   Ueno, Yoshitaka ^a   Imai, Kohsuke ^b   Morio, Tomohiro ^b   Ohara, Osamu ^c   Chayama, Kazuaki ^a   Kobayashi, Masao ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KAZUSA DNA RESEARCH INSTITUTE   (Japan)

Author keywords

Autosomal dominant immune dysregulation syndrome; CTLA 4; FOXP3; Gastric cancer; Regulatory T cells

Indexed keywords

ANTIBIOTIC AGENT; CD19 ANTIGEN; CD28 ANTIGEN; CORTICOSTEROID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GANCICLOVIR; IMMUNOGLOBULIN; INSULIN; PROTON PUMP INHIBITOR; TRANSCRIPTION FACTOR FOXP3;

ACUTE HEPATITIS; ACUTE PANCREATITIS; ADULT; ARTICLE; ATROPHIC GASTRITIS; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT IMMUNE DYSREGULATION SYNDROME; B LYMPHOCYTE; BACTERIAL PNEUMONIA; CANCER SURGERY; CASE REPORT; CAUSE OF DEATH; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLS; CHRONIC DIARRHEA; CHRONIC GASTRITIS; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; EMBRYO; ESOPHAGUS CANDIDIASIS; FEMALE; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; GENE FREQUENCY; GENE INSERTION; GENE SEQUENCE; GENETIC TRANSFECTION; HAPLOINSUFFICIENCY; HELICOBACTER INFECTION; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DYSREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTESTINE METAPLASIA; JAPANESE (PEOPLE); KLEBSIELLA PNEUMONIAE INFECTION; LOSS OF FUNCTION MUTATION; LYMPHOCYTE ACTIVATION; MALE; NATURAL KILLER CELL; ONSET AGE; PERCUTANEOUS DRAINAGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMOMEDIASTINUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; RETROPERITONEAL ABSCESS; STOMACH ADENOCARCINOMA; STOMACH EROSION; STOMACH LESION; SUBSTITUTION THERAPY; UREA BREATH TEST; ADENOCARCINOMA; DNA MUTATIONAL ANALYSIS; FATALITY; GENETIC PREDISPOSITION; GENETICS; INFECTION; JAPAN; METABOLISM; MUTATION; PEDIGREE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH NEOPLASMS;

ADENOCARCINOMA; ADULT; CTLA-4 ANTIGEN; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; GENETIC PREDISPOSITION TO DISEASE; HAPLOINSUFFICIENCY; HUMANS; INFECTION; JAPAN; MALE; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 84958170094     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-015-0221-x     Document Type: Article

References (8)

1. Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014;345(6204):1623–7.
2. Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410–6.
3. Bakacs T, Mehrishi JN. Anti-CTLA-4 therapy may have mechanisms similar to those occurring in inherited human CTLA4 haploinsufficiency. Immunobiology. 2015;220(5):624–5.
4. Kamae C, Nakagawa N, Sato H, Honma K, Mitsuiki N, Ohara O, et al. Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin kappa-deleting recombination excision circles. J Allergy Clin Immunol. 2013;131(5):1437–40 e5.
5. Compare D, Rocco A. Nardone G risk factors in gastric cancer. Eur Rev Med Pharmacol Sci. 2010;14(4):302–8.
6. Zeissig S, Petersen BS, Tomczak M, Melum E, Huc-Claustre E, Dougan SK, et al. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4. Gut. 2014;64(12):1889–97.
7. Dhalla F, da Silva SP, Lucas M, Travis S. Chapel H review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165(1):1–7.
8. Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130(3):495–500.